# Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

> **NCT00726830** · NA · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 1 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors
- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Lymphoproliferative Disorder
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms
- Pain
- Precancerous Condition
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** methadone hydrochloride
- **DRUG:** morphine sulfate
- **DRUG:** oxycodone hydrochloride

## Key facts

- **NCT ID:** NCT00726830
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2010-09
- **Final completion:** 2010-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low Accrual.
- **Last updated:** 2020-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00726830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00726830, "Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00726830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*